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dle ear effusion, led to a decrease in intracochlear ECoG sig-
nal amplitudes. This was not attributable to changes of co-
chlear function. All persistent reductions in ECoG response 
magnitude after normalization of the tympanogram oc-
curred during the first week following implantation. Thresh-
olds of ECoG signals were at or below hearing thresholds in 
all cases.  Conclusion: Gross intracochlear trauma during sur-
gery appears to be rare. In the early postoperative phase the 
ability to assess cochlear status by ECoG recordings was lim-
ited due to the regular occurrence of middle ear effusion. 
Still, intracochlear ECoG along with tympanogram record-
ings suggests that any changes of low-frequency cochlear 
function occur mainly during the first week after cochlear 
implantation. ECoG seems to be a promising tool to objec-
tively assess changes in cochlear function in cochlear im-
plant recipients and may allow further insight into the mech-
anisms underlying the loss of residual hearing. 
 © 2015 S. Karger AG, Basel 
 Introduction 
 As cochlear implant performance has improved, pa-
tients with residual hearing have become candidates for 
this intervention. With this widening of indication, pres-
ervation of residual acoustic hearing has gained clinical 
importance. Hearing preservation is attempted for all co-
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 Abstract 
 Objective: To monitor cochlear function by extra- and intra-
cochlear electrocochleography (ECoG) during and after co-
chlear implantation and thereby to enhance the under-
standing of changes in cochlear function following cochlear 
implantation surgery.  Methods: ECoG responses to acoustic 
stimuli of 250, 500 and 1,000 Hz were recorded in 9 cochlear 
implant recipients with presurgical residual hearing. During 
surgery extracochlear ECoG recordings were performed 
 before and after insertion of the cochlear implant electrode 
array. After insertion of the electrode array, intracochlear 
ECoG recordings were conducted using intracochlear elec-
trode contacts as recording electrodes. Intracochlear ECoG 
recordings were performed up to 6 months after implanta-
tion. ECoG findings were correlated with findings from au-
diometric tests.  Results: Extra- and intracochlear ECoG re-
sponses could be recorded in all subjects. Extracochlear 
ECoG recordings during surgery showed moderate changes. 
Loss or reduction of the ECoG signal at all three frequencies 
did not occur during cochlear implantation. During the first 
week following surgery, conductive hearing loss, due to mid-
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chlear implant recipients with residual hearing nowadays 
[Carlson et al., 2011]. However, complete or partial loss 
of residual hearing still occurs in the majority of cochlear 
implant recipients [Anagiotos et al., 2015; Balkany et al., 
2006]. The underlying mechanisms behind this hearing 
loss are controversial. An objective measurement to mon-
itor intra- and postoperative changes in cochlear function 
could prove useful to enhance the understanding of 
mechanisms leading to such threshold shifts.
 Electrocochleography (ECoG) is a method to objec-
tively assess cochlear function. For clinical purposes, it 
has mainly been used in the diagnostic evaluation of Mé-
nière’s disease [Gibson et al., 1977]. Different potentials 
combine to produce the ECoG signal. The cochlear mi-
crophonic (CM) is produced by hair cells. The auditory 
nerve neurophonic (ANN) and the compound action po-
tential represent neural responses. The summating po-
tential is most likely a signal consisting of hair cell as well 
as neural components [Forgues et al., 2014; Sellick et al., 
2003; van Emst et al., 1995]. The portion of the ECoG sig-
nal which occurs after the compound action potential and 
lasts for the duration of the acoustic stimulus is called the 
ongoing ECoG response. Recent studies defined the am-
plitude of the ongoing ECoG response as the sum of the 
response amplitude at the stimulation frequency (i.e. fun-
damental frequency or first harmonic) and the frequency 
of the second harmonic [Calloway et al., 2014; Fitzpatrick 
et al., 2014; Formeister et al., 2014; McClellan et al., 2014]. 
By this definition, the CM and the ANN contribute to the 
ongoing ECoG response. Summation or averaging of two 
ECoG responses with alternating starting phases is some-
times used to separate CM from ANN. However, it was 
recently demonstrated that this cannot be done at low 
frequency and high intensities [Forgues et al., 2014].
 Objective assessment of cochlear trauma during co-
chlear implantation has been attempted by ECoG record-
ed from extracochlear sites [Calloway et al., 2014; Dalbert 
et al., 2015; Mandala et al., 2012; Radeloff et al., 2012]. 
Radeloff et al. evaluated the detection threshold of CM 
during cochlear implantation. They found changes in only 
2 out of 4 patients with deep electrode array insertions de-
spite complete hearing loss in all 4 patients 1 week after 
surgery. Mandala et al. found a correlation between a re-
duction in compound action potential amplitude during 
insertion of the electrode array and hearing preservation 
rates 4 weeks after surgery. In our own series [Dalbert et 
al., 2015], we evaluated the reduction of the ongoing ECoG 
response at suprathreshold intensities during cochlear 
implantation. These recordings indicated that gross intra-
cochlear trauma only occurred in 1 out of 18 subjects.
 To our knowledge, two reports discussing intracochle-
ar ECoG recordings in humans have been published [Cal-
loway et al., 2014; Campbell et al., 2014]. Calloway et al. 
correlated round window ECoG recordings with record-
ings made from a few millimeters inside the basal turn. 
Additionally, in 8 subjects a temporary lateral cochlear 
wall electrode was inserted for some distance into the sca-
la tympani for intracochlear ECoG recordings. They 
found larger responses for intracochlear recording sites 
in the majority of subjects. On average signal amplitude 
increased with increasing electrode insertion depth. 
Campbell et al. used the cochlear implant itself as record-
ing electrode. ECoG recordings in 5 subjects with some 
residual hearing after cochlear implantation proved the 
feasibility of intracochlear ECoG recordings through the 
cochlear implant.
 The combination of extracochlear ECoG recordings 
during surgery and intracochlear ECoG recordings after-
wards could allow a monitoring of cochlear function dur-
ing and after cochlear implantation. The aim of this study 
was to evaluate such an approach and thereby to enhance 
the understanding of changes in cochlear function fol-
lowing cochlear implantation.
 Materials and Methods 
 All subjects were adult candidates for cochlear implantation 
with a HiFocus TM Mid-Scala electrode array (Advanced Bionics, 
Stäfa, Switzerland) and provided written informed consent prior 
to their surgery. The study protocol was approved by the Ethical 
Committee of Zurich (KEK-ZH No. 2013-0317) and was written 
in concordance with the Helsinki Declaration.
 Array Description 
 The HiFocus Mid-Scala electrode is a precurved array designed 
to achieve a position in the middle of the scala tympani. The diam-
eter is 0.5 mm at the first contact (most apical) and 0.7 mm at the 
sixteenth (most basal). The electrode array is 18.5 mm long. It is 
designed for conventional cochlear implantation and cochlear im-
plantation with intended preservation of residual hearing.
 Audiometric Assessment 
 Pure-tone audiograms were conducted in accordance with ISO 
8253-1. Presurgical pure-tone audiograms were performed within 
6 weeks prior to surgery. Postsurgical pure-tone audiograms were 
performed 4 weeks after surgery and after each ECoG recording 
session. Tympanometry was conducted after each postoperative 
pure-tone audiogram. Air conduction thresholds were evaluated. 
Maximum audiometer output was 100 dB HL at 250 Hz and 120 dB 
HL at 500 and 1,000 Hz. If a response was considered as vibrotactile, 
or questionably vibrotactile, it was considered as no response. If at 
a certain frequency no response was present at the maximum out-
put of the audiometer, the maximum output +5 dB was used [Bal-
kany et al., 2006; Kiefer et al., 2004]. The average of hearing thresh-
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olds at 250, 500 and 1,000 Hz was calculated to represent the re-
maining low-frequency hearing. Differences in hearing threshold 
were calculated from the mean low-frequency hearing. Three hear-
ing preservation categories were defined by the change in mean 
low-frequency hearing [Balkany et al., 2006]: (1) complete hearing 
preservation (mean low-frequency hearing loss of  ≤ 10 dB), (2) par-
tial hearing preservation (mean low-frequency hearing loss of >10 
dB but some remaining low-frequency hearing), and (3) no hearing 
preservation (complete loss of residual hearing). The differences in 
mean low-frequency hearing and the hearing preservation category 
were assessed in the last postoperative pure-tone audiogram. Hear-
ing change in the contralateral ear was assessed to control for natu-
ral progression of hearing loss unrelated to cochlear implantation.
 Surgery 
 Following a retroauricular incision, an anterior mastoidectomy 
and a posterior tympanotomy were performed in the usual fash-
ion. After complete visualization of the round window, the record-
ing electrode (Neurosign, Magstim Co., Whitland, UK) used for 
extracochlear ECoG recordings was placed on the promontory and 
remained in an unchanged position for the rest of the surgery (i.e. 
before and after electrode array insertion). Fixation of the record-
ing electrode was achieved in the mastoidectomy cavity by bone 
wax. If the impedance of the recording electrode exceeded 10 kΩ, 
a resorbable gelatin sponge (Spongostan, Ethicon Inc., Sommer-
ville, Mass., USA) was placed around the recording electrode. After 
completion of these steps, preinsertional extracochlear ECoG re-
cordings were conducted. Afterwards the HiFocus Mid-Scala elec-
trode array was slowly inserted through a round window approach 
and the insertion site sealed with periosteum. Extracochlear ECoG 
recordings were then repeated. Afterwards the recording electrode 
was removed and the incision closed in layers. During closure of 
the incision, intraoperative ECoG recordings were conducted 
from the intracochlear site using the HiFocus Mid-Scala electrode 
array as recording electrode.
 ECoG Recordings 
 For extracochlear ECoG recordings, the Navigator Pro stimula-
tion/recording device from Biologic Systems (Mundelein, Ill., USA) 
and the AEP software, version 7.0.0 (Mundelein), were used for 
acoustic stimulation and recordings. As recording electrodes, nee-
dle electrodes (Neurosign, Magstim Co.) were placed on the prom-
ontory (‘positive’) as described above, in the contralateral preau-
ricular region (‘negative’) and on the forehead (‘ground’). Acoustic 
stimuli were delivered by sterilized foam insert earphones (Biologic 
Systems). Responses to 400 tone bursts with alternating starting 
phases at 250, 500 and 1,000 Hz were recorded. Rise/fall times were 
2 cycles and were shaped by a Blackman window. The plateau phase 
was 4 cycles at 250 Hz, 10 cycles at 500 Hz and 20 cycles at 1,000 Hz. 
Sound pressure for extracochlear ECoG recordings was 80 dB HL 
at 250 Hz, 85 dB HL at 500 Hz and 90 dB HL at 1,000 Hz. The re-
cording window was 32 ms, starting 4 ms before stimulus presenta-
tion. The sampling rate was 8,000 Hz for the 250- and 500-Hz stim-
uli and 16,000 Hz for the 1,000-Hz stimuli. The recording amplifi-
er’s high pass filter was set at 10 Hz and the low pass filter at 5,000 Hz. 
For artifact rejection, a 47.5-μV threshold was selected.
 For intracochlear ECoG recordings through the HiRes90K TM 
cochlear implant system (Advanced Bionics), the Bionic Ear Data 
Collection System (BEDCS; Advanced Bionics), version 1.18, was 
used. The BEDCS software was connected to the cochlear implant 
through the Clarion Programming Interface (Advanced Bionics) 
and the Platinum Series Speech Processor (Advanced Bionics). 
The BEDCS was configured for the cochlear implant system in re-
cording mode with a gain of 1,000 Hz and a recording duration of 
50 ms. The sampling rate was 9,000 Hz. The low pass filter was set 
at 5,000 Hz. If not otherwise declared, the most apical contact of 
the HiFocus Mid-Scala electrode array was used as recording elec-
trode. In a subgroup of 6 subjects, ECoG recordings from different 
contacts along the electrode array were conducted. In such record-
ings a value of 0.5 μV, below the noise floor, was assigned for con-
tacts with no measurable ECoG response. The ring electrode was 
used as reference electrode in all cases.
 For acoustic stimulation in intracochlear ECoG recordings, the 
BEDCS software controlled the Clarion Programming Interface, 
providing a trigger input to the Navigator Pro device, thus allowing 
synchronous acoustic stimulation. Acoustic stimuli were delivered 
by foam insert earphones (Biologic Systems). Responses to 90–270 
tone bursts with alternating starting phases at 250, 500 and 1,000 Hz 
were recorded. Rise/fall times were 2 cycles and were shaped by a 
Blackman window. Plateau phases were 5 cycles at 250 Hz, 14 cycles 
at 500 Hz and 32 cycles at 1,000 Hz. The stimulus rate was 10 Hz, 
with the maximum sound pressure 80 dB HL at 250 Hz, 85 dB HL at 
500 Hz and 90 dB HL at 1,000 Hz. In postoperative recording ses-
sions after 4 or more weeks, level series with 5- to 10-dB steps were 
taken until threshold. In recording sessions during surgery, after 
1 day and after 1 week, threshold determination was not pursued and 
recordings were conducted at the maximum sound pressure level.
 Postoperative intracochlear ECoG recordings were conducted 
only during regular follow-up visits. The study protocol did not 
allow additional visits for research purposes only. Recordings with 
disconnected loud speakers to control for electrical artifacts were 
conducted after each extra- and intracochlear ECoG recording ses-
sion at maximum sound pressure. Sound pressure in the ear canal 
was monitored by a probe microphone (ER-7C, Etymotic Inc., Elk 
Grove Village, Ill., USA) placed near the tympanic membrane dur-
ing all intraoperative recordings.
 Data Analysis 
 AEP to ASCII software from Biologic Systems was used to export 
data from the AEP software. MATLAB (MathWorks Inc., Natick, 
Mass., USA) as well as GraphPad Prism V5.04 (GraphPad Software 
Inc., San Diego, Calif., USA) were used for further postprocessing.
 The ECoG responses from rarefaction and condensation phases 
were stored separately. A difference curve was obtained by subtract-
ing the average of the condensation from the average of the rarefac-
tion phase and an alternating curve was obtained from the sum of 
both averages. A fast Fourier transform (FFT) was used to obtain 
the spectrum of each response. The response amplitude was mea-
sured at the frequency of the stimulus signal and at its first harmon-
ic. The sum of both amplitudes was defined as the amplitude of the 
ongoing ECoG response at the frequency of the acoustic stimulus.
 Based on the total response as defined by Fitzpatrick et al. [Cal-
loway et al., 2014; Fitzpatrick et al., 2014; Formeister et al., 2015; 
McClellan et al., 2014], the sum of the magnitudes of valid ECoG 
responses at maximum sound pressure level for 250, 500 and 1,000 
Hz was taken as a measure of the cochlear function at low frequen-
cies. The sum is termed as the low-frequency ECoG response in 
the remainder of this article.
 The noise floor was determined differently for extra- and intra-
cochlear ECoG recordings. In extracochlear ECoG recordings, a re-
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sponse was considered valid if the amplitude exceeded the calculated 
noise floor + 3 standard deviations. The means of the noise floor and 
its standard deviations were calculated from all bins within 150–200 
Hz and 300–350 Hz for 250 Hz, within 400–450 Hz and 550–600 Hz 
for 500 Hz, and within 900–950 Hz and 1,050–1,100 Hz for 1,000 Hz.
 For intracochlear ECoG recordings, the noise floor was deter-
mined at the beginning of each recording session from the average 
of 270 recordings without acoustic input. Individual traces from 
each recording step were stored. The bootstrap method [Efron and 
Tibshirani, 1993] was utilized to construct the 99% confidence in-
terval for each ECoG frequency component. For each bootstrap 
iteration, individual traces were drawn from the full set and recom-
bined into a bootstrapped average trace. An FFT analysis was per-
formed on the trace and stored. The resampling operation was 
repeated 1,000 times. The confidence interval for each FFT bin was 
computed by determining the observed 99% percentile value of the 
bootstrapped FFT outputs for each frequency bin. The presence of 
an ECoG component was judged as significant only if the frequen-
cy of the component related to the stimulus frequency and the am-
plitude of the component exceeded the confidence interval.
 Results 
 Nine subjects were included. Subject 4 agreed to intra-
operative recordings but declined further ECoG record-
ings during follow-up visits due to additional expenditure 
of time. In all subjects except subject 4, the etiology of 
hearing loss was unknown. Subject 4 had otosclerosis. All 
subjects had a history of hearing loss of more than 
10 years. Subject demographics and audiometric findings 
are summarized in  table 1 .
 Mean low-frequency hearing loss was 15.6 dB (range 
from –6.6 to 38.4 dB) 4 weeks after surgery. Pure-tone 
audiograms after 12 or more weeks showed no further 
decline in low-frequency hearing. On the contrary, sub-
jects 2, 3, 5 and 6 showed a slight improvement in low-
frequency hearing thresholds. The mean difference in 
low-frequency hearing thresholds between 4 and 12 or 
more weeks was –5.3 dB (range from –8.3 to 0 dB).
 If residual hearing was present on the contralateral 
side, the mean loss in low-frequency hearing was 1.8 dB 
(range from –5 to 3.3 dB). Subjects 3 and 9 had no resid-
ual hearing on the contralateral side.
 There were 4 subjects with complete hearing preserva-
tion, and 4 had hearing partially preserved. Only subject 
9 showed a complete loss of residual hearing.
 Tympanograms revealed middle ear effusion in all 
subjects, both 1 day and 1 week after surgery. Clinical in-
spection showed a hematotympanon in all cases. Tympa-
nograms and otoscopic findings were normal in all sub-
jects 4 or more weeks after surgery.
 Extracochlear ECoG Recordings 
 Extracochlear ECoG recordings were obtained in all 
subjects. No valid responses were detectable at 500 and 
1,000 Hz in subject 8 and at 1,000 Hz in subjects 2 and 6. 
Before insertion of the electrode array, the mean ECoG 
response amplitude relative to 0.1 μV was 21.5 dB at 
250 Hz, 17.3 dB at 500 Hz and 15.5 dB at 1,000 Hz. Mean 
changes in ECoG response amplitude were 2.6 dB at 
250  Hz (range from –2.4 to 7.4 dB), 2.6 dB at 500 Hz 
(range from –4.9 to 8.4 dB) and 3 dB at 1,000 Hz (from 
–0.7 to 8.6 dB). The mean change in low-frequency ECoG 
response was 1.8 dB with a range from –2 to 5.1 dB.  Fig-
ure  1 shows an example for pre- and postinsertional 
ECoG signals at 250, 500 and 1,000 Hz recorded from the 
extracochlear site.
 Intracochlear ECoG Recordings at Suprathreshold 
Intensities 
 Intracochlear ECoG recordings during surgery showed 
a valid ECoG signal in at least one frequency for all sub-
jects. Subjects 1 and 8 showed no valid responses at 500 
and 1,000 Hz, and subjects 2, 4, 6 and 9 showed no re-
sponse at 1,000 Hz. Intraoperative recordings showed 
mean ECoG response amplitudes, relative to 0.1 μV, of 
42.6 dB at 250 Hz, 37.4 dB at 500 Hz and 20.7 dB at 
1,000 Hz.  Figure 2 shows a typical intracochlear ECoG 
response ( fig.  2 a, b) and compares a signal recorded 
through the cochlear implant with a signal recorded from 
the extracochlear site ( fig. 2 c). 
 Table 1.  Subject demographics and audiometric findings
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 Fig. 1. Examples of ECoG signals recorded from the extracochlear 
site during cochlear implantation at 250 ( a ), 500 ( b ) and 1,000 Hz 
( c ). The difference of both ECoG responses with alternating start-
ing phases before (dotted line) and after (solid line) insertion of the 
cochlear implant electrode array is shown. 
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 Fig. 2. ECoG signals recorded through the cochlear implant at 250 
Hz and 80 dB HL in subject 3 ( a ,  b ) and subject 5 ( c ).  a The difference 
of both ECoG responses with alternating starting phases.  b The sum 
of both ECoG responses with alternating starting phases.  c Com-
parison of the ECoG signal recorded after insertion of the electrode 
array from the extracochlear site and the ECoG signal recorded 
through the cochlear implant during surgery. The intracochlear re-
cording shows a larger ECoG response. This can be explained by the 
closer location of the electrodes to the generators of the ECoG signal 
in intracochlear recordings compared to extracochlear recordings. 
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 Postoperative intracochlear ECoG recordings were 
conducted for 8 subjects. However, a comparison be-
tween intra- and postoperative ECoG recordings at su-
prathreshold intensities was not possible in subjects 
1 and 2 since the stimulation level used during intraop-
erative ECoG recordings was not tolerated postopera-
tively.
 Figure 3 shows the change in low-frequency ECoG re-
sponse at suprathreshold intensities over time for sub-
jects 3, 5, 6, 7, 8 and 9. Subjects 3 and 5 showed a similar 
pattern. Following a reduction of the response after 24 h, 
signals remained relatively stable until 24 weeks after sur-
gery. For subject 6, the response was smaller after 1 week 
compared to intraoperative findings, but surpassed the 
magnitude of intraoperative recordings after 4 weeks. 
Then after 4 weeks the response remained stable. For sub-
jects 7 and 9, a reduction of the response magnitude was 
detectable after 1 week. This reduction was reversible in 
subject 7 but remained stable in subject 9. Subject 8 had 
only 1 postoperative recording session after 4 weeks, 
showing an almost unchanged response.
 Intracochlear ECoG recordings using different con-
tacts of the cochlear implant’s electrode array were con-
ducted in subjects 1, 2, 3, 5 and 6 in 1 postoperative re-
cording session after 12 or more weeks. Findings for dif-
ferent frequencies – normalized to the ECoG response 
magnitude at the most apical contact – are summarized 
in  figure 4 .
 Comparison of Hearing Threshold and ECoG Signal 
 Thresholds of the ongoing ECoG signal were deter-
mined in postoperative recordings for 8 subjects. Com-
parison between hearing threshold and threshold of the 
ongoing ECoG signal revealed a threshold of the ongoing 
ECoG signal at or below the hearing threshold in all cases 
( fig. 5 ).  Figure 6 shows examples of level series at all 3 fre-
quencies.
 Additionally, the change in the low-frequency ECoG 
response over time and the hearing preservation catego-
ries were compared in subjects 3, 5, 6, 7, 8 and 9. In sub-
jects 3 and 5 with a reduction of the ECoG response after 
24 h and afterwards stable conditions, partial (subject 3) 
and complete (subject 5) hearing preservation could be 
achieved. In subject 6 with complete hearing preserva-
tion, the low-frequency ECoG response showed a larger 
magnitude after 4 weeks when compared to intraopera-
tive recordings. Partial hearing preservation in subjects 
7 and 8 was associated with almost unchanged responses 
after 4 weeks. Subject 9 with a complete hearing loss 
showed a markedly reduced low-frequency ECoG re-
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sponse after 1 week. This reduction persisted until 4 weeks 
after surgery and was associated with a complete loss of 
the ECoG signals at 500 and 1,000 Hz.
 Discussion 
 This study assessed a combination of extra- and intra-
cochlear ECoG recordings in cochlear implant recipi-
ents. Such recordings could allow a recurrent objective 
assessment of cochlear status during and after cochlear 
implantation and thereby could enhance the under-
standing of mechanisms responsible for the loss of re-
sidual hearing.
 Extracochlear ECoG recordings were performed to as-
sess the cochlear trauma during insertion of the electrode 
array. We monitored the ongoing ECoG signal at supra-
threshold intensities as a decrease in this signal has been 
the most sensitive marker for cochlear trauma in animal 
studies [Adunka et al., 2010; Ahmad et al., 2012; Camp-
bell et al., 2010; Choudhury et al., 2011, 2014; DeMason 
et al., 2012]. Gross intracochlear trauma (e.g. rupture of 
the basilar membrane) should cause an immediate reduc-
tion or loss of the ECoG signal [Adunka et al., 2010; Ah-
mad et al., 2012; Campbell et al., 2010; Choudhury et al., 
2011, 2014; DeMason et al., 2012]. In our series, the larg-
est decrease in the ECoG signal was 4.9 dB at 500 Hz. This 
was not associated with a decrease at 250 or 1,000 Hz. No 
subject showed a loss of ECoG response, or a decrease in 
ECoG signal, at all three frequencies. Therefore, accord-
ing to extracochlear ECoG recordings before and after 
insertion of the cochlear implant electrode array, no gross 
cochlear trauma occurred during surgery.
 The ability to assess changes of cochlear function by 
intracochlear ECoG was limited during the first week 
due to the regular presence of a hematotympanon. As 
the associated conductive hearing loss led to a decrease 
in the sound pressure reaching the inner ear, a decrease 
in the ECoG signal resulted which is most likely not 
attributable to changes in cochlear function. It was not 
possible to distinguish between changes of the ECoG 
signal caused by middle ear effusion and those caused 
by intracochlear processes. However, in cases where 
the reduction of the ECoG response was not reversible 
after normalization of the tympanogram, it is plausible 
to assume that changes represent, at least partly, a de-
terioration of cochlear function. Therefore, our results 
suggest that changes in cochlear function mainly occur 
during the first week after cochlear implantation. Find-
ings in subjects 3 and 5 suggest that while no change 
in extracochlear recordings occurred during surgery, 
loss of cochlear function took place during the first 
24 h after surgery. This finding fits well with the hy-
pothesis that early inflammatory responses play a 
prominent role in the loss of residual hearing [Kel et 
al., 2013].
 Subject 6 showed an increase in the low-frequency 
ECoG response after 4 weeks compared to intraoperative 
recordings. As intraoperative ECoG recordings through 
the cochlear implant were conducted during closure of 
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the incision, a rapid progression of middle ear effusion 
could be an explanation for this.
 ECoG signal magnitudes after 4 or more weeks re-
mained relatively stable in all subjects. In concordance, 
pure-tone audiograms showed stable thresholds without 
progressive loss of residual hearing. In the literature, such 
a progressive loss of residual hearing over a long time pe-
riod is reported to occur in about 20% of cochlear implant 
recipients [Gstoettner et al., 2006].
 With the technique presented here a quantitative com-
parison between intra- and extracochlear ECoG record-
ings is not feasible because of the use of two different re-
cording systems having different signal-to-noise ratios. 
By design, the cochlear implant amplifier has a higher 
noise floor than regular amplifiers such as the Biologic 
Navigator Pro used in this study for extracochlear ECoG 
recordings. This means ECoG signals had to be larger, or 
more averages had to be accumulated, in intracochlear 
ECoG recordings to have comparable signal-to-noise ra-
tios between both systems. However, the fact that the 
mean ECoG response amplitude relative to 0.1 μV was 
18.1 dB in extracochlear recordings and 33.5 dB in re-
cordings through the cochlear implant supports the as-
sumption that ECoG recordings from an intracochlear 
site usually produce larger signals. This finding is in con-
cordance with results published by Calloway et al. [2014] 
and can most likely be explained with a closer location to 
the generators of the ECoG signal in intracochlear re-
cording.
 In concordance with previous studies, intracochlear 
recordings from different intracochlear sites showed 
findings varying based on stimulus frequency. Calloway 
et al. [2014] found a clear trend toward larger signals at 
500 Hz with increasing insertion depth of the temporary 
lateral wall electrode. However, when recording from 
different intracochlear sites using different contacts of 
the electrode array, Campbell et al. [2015] could not de-
tect such a clear trend for 1,000 Hz but showed similar 
results for 500 Hz. Compared to signal amplitudes from 
the middle of the electrode array, basal contacts detected 
an increase in CM in 1 out of 3 subjects and of ANN in 2 
out of 3 subjects. As the distinction between CM and 
ANN is not possible at low frequencies [Forgues et al., 
2014], we only assessed the magnitude of the ongoing 
ECoG signal. However, in 4 recordings at 500 Hz and at 
1,000 Hz, we could also detect larger responses of the on-
going ECoG signal in recordings from more basal con-
tacts. On average, the expected trend of larger amplitudes 
for more apical contacts was present at 250 Hz. This was 
not the case at 500 and 1,000 Hz. A larger neural contri-
bution due to proximity to the auditory nerve, or as out-
lined by Campbell et al. [2014] the extent and nature of 
the foreign body reaction to the electrode array, could 
play a role.
 In concordance with previous reports [Campbell et 
al., 2014; Choudhury et al., 2012], comparison between 
intracochlear recordings and behavioral hearing thresh-
olds revealed ECoG signal thresholds at or below be-
havioral hearing thresholds in all cases. As suggested by 
Choudhury et al. [2012], this is probably caused by the 
CM which as a hair cell response does not directly 
translate into hearing. Accordingly, postoperative 
changes of the low-frequency ECoG response over time 
did not directly reflect changes of the hearing threshold. 
However, in subject 9, where there was a complete loss 
of residual hearing, postoperative ECoG recordings 
showed a large decrease in the low-frequency ECoG re-
sponse and a complete loss of ECoG responses at 500 
and 1,000 Hz, indicating a marked loss of cochlear 
function. 
 Conclusion 
 Findings suggest that gross cochlear trauma during 
surgery is rare and that changes in cochlear function for 
low-frequency regions mainly occur during the early 
postoperative phase. With the technique we present, the 
regular presence of middle ear effusion in the first days 
following surgery limits the ability to assess the extent of 
deterioration in cochlear function in the early postopera-
tive phase. Overall, ECoG recordings from extra- as well 
as intracochlear sites along with tympanogram findings 
are able to provide additional information on changes in 
cochlear status for cochlear implant recipients and seem 
to hold great potential to enhance our understanding of 
the mechanisms leading to loss of residual hearing in co-
chlear implant recipients.
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